A recent study has demonstrated that 82.5% of the Japanese IMT cases had rearrangements involving either ALK, NTRK3, or ROS112, indicating that racial differences might be less likely to cause the low frequency of gene fusion/rearrangement. This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.